Australia markets closed

CONMED Corporation (CNMD)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
84.97+1.63 (+1.96%)
At close: 4:00PM EDT
Show:
Income statement
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2019
31/12/2018
31/12/2017
31/12/2016
Total revenue
870,252
955,097
859,634
796,392
763,520
Cost of revenue
407,076
430,382
390,524
365,351
355,190
Gross profit
463,176
524,715
469,110
431,041
408,330
Operating expenses
Research development
41,899
45,460
42,188
32,307
32,254
Selling general and administrative
380,532
400,141
355,617
351,799
338,400
Total operating expenses
422,431
445,601
397,805
384,106
370,654
Operating income or loss
40,745
79,114
71,305
46,935
37,676
Interest expense
42,486
42,701
20,652
18,203
15,359
Total other income/expenses net
-820
-5,188
-
-
-2,942
Income before tax
-2,561
31,225
50,653
28,732
19,375
Income tax expense
-2,992
2,605
9,799
-26,755
4,711
Income from continuing operations
431
28,620
40,854
55,487
14,664
Net income
431
28,620
40,854
55,487
14,664
Net income available to common shareholders
431
28,620
40,854
55,487
14,664
Basic EPS
-
1.01
1.45
1.99
0.53
Diluted EPS
-
0.97
1.41
1.97
0.52
Basic average shares
-
28,325
28,118
27,939
27,804
Diluted average shares
-
29,495
28,890
28,171
27,964
EBITDA
-
146,249
133,108
105,483
90,043